The results are in, and a recent clinical trial for a preventative HIV drug has come back with shocking effectiveness. According to reports in The Conversation, trials of a new prophylaxis drug can help prevent HIV infections in women better than two other PrEP drugs that are currently on the market.
Further, the researchers involved with the most recent clinical trial discovered that over a six-month period, the medication had a 100% success rate when delivered via injection just twice a year.